메뉴 건너뛰기




Volumn 54, Issue 3, 2009, Pages 339-348

Cardiovascular Risk and Antiangiogenic Therapy for Age-related Macular Degeneration

Author keywords

age related macular degeneration; angiogenesis; antiangiogenic drugs; atherosclerosis; atherothrombosis; cardiovascular risk; myocardial infarction; stroke

Indexed keywords

BEVACIZUMAB; PEGAPTANIB; PLACENTAL GROWTH FACTOR; RANIBIZUMAB; VASCULOTROPIN; VASCULOTROPIN B; VASCULOTROPIN C; VASCULOTROPIN D; VERTEPORFIN;

EID: 65349115442     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.survophthal.2009.02.003     Document Type: Review
Times cited : (47)

References (87)
  • 1
    • 0027942607 scopus 로고
    • Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
    • Aiello L.P., Avery R.L., Arrigg P.G., et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331 (1994) 1480-1487
    • (1994) N Engl J Med , vol.331 , pp. 1480-1487
    • Aiello, L.P.1    Avery, R.L.2    Arrigg, P.G.3
  • 2
    • 33748982649 scopus 로고    scopus 로고
    • Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy
    • Avery R.L., Pearlman J., Pieramici D.J., et al. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 113 (2006) 1695-1705
    • (2006) Ophthalmology , vol.113 , pp. 1695-1705
    • Avery, R.L.1    Pearlman, J.2    Pieramici, D.J.3
  • 3
    • 0033021175 scopus 로고    scopus 로고
    • Role of smooth muscle cell death in advanced coronary primary lesions: implications for plaque instability
    • Bauriedel G., Hutter R., Welsch U., et al. Role of smooth muscle cell death in advanced coronary primary lesions: implications for plaque instability. Cardiovasc Res 41 (1999) 480-488
    • (1999) Cardiovasc Res , vol.41 , pp. 480-488
    • Bauriedel, G.1    Hutter, R.2    Welsch, U.3
  • 4
    • 0029805172 scopus 로고    scopus 로고
    • Nitric oxide, superoxide and peroxynitrite: the good, the bad and the ugly
    • Beckman J.S., and Koppenol W.H. Nitric oxide, superoxide and peroxynitrite: the good, the bad and the ugly. Am J Physiol 271 (1996) C1424-C1437
    • (1996) Am J Physiol , vol.271
    • Beckman, J.S.1    Koppenol, W.H.2
  • 6
    • 0035051114 scopus 로고    scopus 로고
    • Treatment of ischemic wounds using cultured dermal fibroblasts transduced retrovirally with PDGF-B and VEGF121 genes
    • Breitbart A.S., Grande D.A., Laser J., et al. Treatment of ischemic wounds using cultured dermal fibroblasts transduced retrovirally with PDGF-B and VEGF121 genes. Ann Plast Surg 46 (2001) 555-561
    • (2001) Ann Plast Surg , vol.46 , pp. 555-561
    • Breitbart, A.S.1    Grande, D.A.2    Laser, J.3
  • 7
    • 0142089171 scopus 로고    scopus 로고
    • Prognostic value of myeloperoxidase in patients with chest pain
    • Brennan M.L., Penn M.S., Van Lente F., et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 349 (2003) 1595-1604
    • (2003) N Engl J Med , vol.349 , pp. 1595-1604
    • Brennan, M.L.1    Penn, M.S.2    Van Lente, F.3
  • 8
    • 1942542429 scopus 로고    scopus 로고
    • Age-related macular degeneration is the leading cause of blindness
    • Bressler N.M. Age-related macular degeneration is the leading cause of blindness. JAMA 291 (2004) 1900-1901
    • (2004) JAMA , vol.291 , pp. 1900-1901
    • Bressler, N.M.1
  • 9
    • 33749451356 scopus 로고    scopus 로고
    • Ranibizumab versus verteporfin for neovascular age-related macular degeneration
    • Brown D.M., Kaiser P.K., Michels M., et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355 (2006) 1432-1444
    • (2006) N Engl J Med , vol.355 , pp. 1432-1444
    • Brown, D.M.1    Kaiser, P.K.2    Michels, M.3
  • 10
    • 0032406276 scopus 로고    scopus 로고
    • HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis
    • Bustos C., Hernández-Presa M.A., Ortego M., et al. HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis. J Am Coll Cardiol 32 (1998) 2057-2064
    • (1998) J Am Coll Cardiol , vol.32 , pp. 2057-2064
    • Bustos, C.1    Hernández-Presa, M.A.2    Ortego, M.3
  • 11
    • 0345167094 scopus 로고    scopus 로고
    • Mobilized endothelial progenitor cells by granulocyte-macrophage colony-stimulating factor accelerate reendothelization and reduce vascular inflammation after Intravascular radiation
    • Cho H.J., Kim H.S., Lee M.M., et al. Mobilized endothelial progenitor cells by granulocyte-macrophage colony-stimulating factor accelerate reendothelization and reduce vascular inflammation after Intravascular radiation. Circulation 108 (2003) 2918-2925
    • (2003) Circulation , vol.108 , pp. 2918-2925
    • Cho, H.J.1    Kim, H.S.2    Lee, M.M.3
  • 12
    • 34147190880 scopus 로고    scopus 로고
    • FDA drug approval summary: bevacizumab plus FOLFOX4 as second-line treatment of colorectal cancer
    • Cohen M.H., Gootenberg J., Keegan P., and Pazdur R. FDA drug approval summary: bevacizumab plus FOLFOX4 as second-line treatment of colorectal cancer. Oncologist 12 (2007) 356-361
    • (2007) Oncologist , vol.12 , pp. 356-361
    • Cohen, M.H.1    Gootenberg, J.2    Keegan, P.3    Pazdur, R.4
  • 13
    • 33746699073 scopus 로고    scopus 로고
    • Age-related macular degeneration and risk for stroke
    • Couper D., Lai H., Hubbard L.D., and Sharrett A.R. Age-related macular degeneration and risk for stroke. Ann Intern Med 145 (2006) 98-107
    • (2006) Ann Intern Med , vol.145 , pp. 98-107
    • Couper, D.1    Lai, H.2    Hubbard, L.D.3    Sharrett, A.R.4
  • 14
  • 15
    • 0029800916 scopus 로고    scopus 로고
    • Stability and instability: two faces of coronary atherosclerosis
    • Davies M.J. Stability and instability: two faces of coronary atherosclerosis. Circulation 94 (1996) 2013-2020
    • (1996) Circulation , vol.94 , pp. 2013-2020
    • Davies, M.J.1
  • 16
    • 0037432168 scopus 로고    scopus 로고
    • Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes
    • de Lemos J.A., Morrow D.A., Sabatine M.S., et al. Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes. Circulation 107 (2003) 690-695
    • (2003) Circulation , vol.107 , pp. 690-695
    • de Lemos, J.A.1    Morrow, D.A.2    Sabatine, M.S.3
  • 17
    • 0034466813 scopus 로고    scopus 로고
    • Pharmacokinetics and safety of an antivascular endothelial growth factor aptamer (NX1838) following injection into the vitreous humor of rhesus monkeys
    • Drolet D.W., Nelson J., Tucker C.E., et al. Pharmacokinetics and safety of an antivascular endothelial growth factor aptamer (NX1838) following injection into the vitreous humor of rhesus monkeys. Pharm Res 17 (2000) 1503-1510
    • (2000) Pharm Res , vol.17 , pp. 1503-1510
    • Drolet, D.W.1    Nelson, J.2    Tucker, C.E.3
  • 18
    • 33947601440 scopus 로고    scopus 로고
    • Age-related macular degeneration is associated with incident myocardial infarction among elderly Americans
    • Duan Y., Mo J., Klein R., et al. Age-related macular degeneration is associated with incident myocardial infarction among elderly Americans. Ophthalmology 114 (2007) 732-737
    • (2007) Ophthalmology , vol.114 , pp. 732-737
    • Duan, Y.1    Mo, J.2    Klein, R.3
  • 19
    • 0000324895 scopus 로고    scopus 로고
    • Pathogenesis of plaque disruption
    • Fuster V., Ross R., and Topol E.J. (Eds), Lippincott-Raven, Philadelphia
    • Falk E., Shah P.K., and Fuster V. Pathogenesis of plaque disruption,. In: Fuster V., Ross R., and Topol E.J. (Eds). Atherosclerosis and Coronary Artery Disease (1996), Lippincott-Raven, Philadelphia 491-507
    • (1996) Atherosclerosis and Coronary Artery Disease , pp. 491-507
    • Falk, E.1    Shah, P.K.2    Fuster, V.3
  • 20
    • 4143136640 scopus 로고    scopus 로고
    • Vascular endothelial growth factor: basic science and clinical progress
    • Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25 (2004) 581-611
    • (2004) Endocr Rev , vol.25 , pp. 581-611
    • Ferrara, N.1
  • 21
    • 0031039243 scopus 로고    scopus 로고
    • The biology of vascular endothelial growth factor
    • Ferrara N., and Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 18 (1997) 4-25
    • (1997) Endocr Rev , vol.18 , pp. 4-25
    • Ferrara, N.1    Davis-Smyth, T.2
  • 22
    • 0037699954 scopus 로고    scopus 로고
    • The biology of VEGF and its receptors
    • Ferrara N., Gerber H.P., and LeCouter J. The biology of VEGF and its receptors. Nat Med 9 (2003) 669-676
    • (2003) Nat Med , vol.9 , pp. 669-676
    • Ferrara, N.1    Gerber, H.P.2    LeCouter, J.3
  • 23
    • 0021752680 scopus 로고
    • Age-related macular degeneration and blindness due to neovascular maculopathy
    • Ferris F.L., Fine S.L., and Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol 102 (1984) 1640-1642
    • (1984) Arch Ophthalmol , vol.102 , pp. 1640-1642
    • Ferris, F.L.1    Fine, S.L.2    Hyman, L.3
  • 24
    • 4844231461 scopus 로고    scopus 로고
    • Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation
    • Fliser D., Buchholz K., Haller H., et al. Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation. Circulation 110 (2004) 1103-1107
    • (2004) Circulation , vol.110 , pp. 1103-1107
    • Fliser, D.1    Buchholz, K.2    Haller, H.3
  • 25
    • 0035956947 scopus 로고    scopus 로고
    • Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability
    • Fukumara D., Gohongi T., Kadambi A., et al. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci USA 98 (2001) 2604-2609
    • (2001) Proc Natl Acad Sci USA , vol.98 , pp. 2604-2609
    • Fukumara, D.1    Gohongi, T.2    Kadambi, A.3
  • 26
    • 0012746898 scopus 로고    scopus 로고
    • Coronary artery disease: a clinical-pathological correlation
    • Fuster V. (Ed), Futura Publishing, New York
    • Fuster V. Coronary artery disease: a clinical-pathological correlation,. In: Fuster V. (Ed). Syndromes of Atherosclerosis (1996), Futura Publishing, New York 1-15
    • (1996) Syndromes of Atherosclerosis , pp. 1-15
    • Fuster, V.1
  • 27
    • 0027125530 scopus 로고
    • The pathogenesis of coronary artery disease and the acute coronary syndromes
    • 310-8
    • Fuster V., Badimon L., Badimon J.J., and Chesebro J.H. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 326 (1992) 242-250 310-8
    • (1992) N Engl J Med , vol.326 , pp. 242-250
    • Fuster, V.1    Badimon, L.2    Badimon, J.J.3    Chesebro, J.H.4
  • 28
    • 13944266313 scopus 로고    scopus 로고
    • Preclinical pharmacokinetics of Ranibizumab (rhuFabV2) after a single intravitreal administration
    • Gaudreault J., Fei D., Rusit J., et al. Preclinical pharmacokinetics of Ranibizumab (rhuFabV2) after a single intravitreal administration. Invest Ophthalmol Vis Sci 46 (2005) 726-733
    • (2005) Invest Ophthalmol Vis Sci , vol.46 , pp. 726-733
    • Gaudreault, J.1    Fei, D.2    Rusit, J.3
  • 29
    • 0032557564 scopus 로고    scopus 로고
    • Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells
    • Gerber H.P., Dixit V., Ferrara N., et al. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J Biol Chem 273 (1998) 13313-13316
    • (1998) J Biol Chem , vol.273 , pp. 13313-13316
    • Gerber, H.P.1    Dixit, V.2    Ferrara, N.3
  • 30
    • 0032931234 scopus 로고    scopus 로고
    • VEGF is required for growth and survival in neonatal mice
    • Gerber H.P., Hillan K.J., Ryan, et al. VEGF is required for growth and survival in neonatal mice. Development 126 (1999) 1149-1159
    • (1999) Development , vol.126 , pp. 1149-1159
    • Gerber, H.P.1    Hillan, K.J.2    Ryan3
  • 31
    • 0032515047 scopus 로고    scopus 로고
    • Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation
    • Gerber H.P., McMurtrey A., Kowalski J., et al. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem 273 (1998) 30336-30343
    • (1998) J Biol Chem , vol.273 , pp. 30336-30343
    • Gerber, H.P.1    McMurtrey, A.2    Kowalski, J.3
  • 32
    • 34248173883 scopus 로고    scopus 로고
    • Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200
    • Giantonio B.J., Catalano P.J., Meropol M.J., et al. Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. J Clin Oncol 25 (2007) 1539-1544
    • (2007) J Clin Oncol , vol.25 , pp. 1539-1544
    • Giantonio, B.J.1    Catalano, P.J.2    Meropol, M.J.3
  • 33
    • 33846973644 scopus 로고    scopus 로고
    • Ranibizumab for neovascular age-related macular degeneration
    • Gillies M.C., and Wong T.Y. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 356 (2007) 748-750
    • (2007) N Engl J Med , vol.356 , pp. 748-750
    • Gillies, M.C.1    Wong, T.Y.2
  • 34
    • 0034255465 scopus 로고    scopus 로고
    • Adenovirus-mediated VEGF(121) gene transfer stimulates angiogenesis in normoperfused skeletal muscle and preserves tissue perfusion after induction of ischemia
    • Gowdak L.H., Poliakova L., Wang X., et al. Adenovirus-mediated VEGF(121) gene transfer stimulates angiogenesis in normoperfused skeletal muscle and preserves tissue perfusion after induction of ischemia. Circulation 102 (2000) 565-571
    • (2000) Circulation , vol.102 , pp. 565-571
    • Gowdak, L.H.1    Poliakova, L.2    Wang, X.3
  • 35
    • 11144239923 scopus 로고    scopus 로고
    • Pegaptanib for neovascular age-related macular degeneration
    • Gragoudas E.S., Adamis A., Cunningham E.T., et al. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351 (2004) 2805-2816
    • (2004) N Engl J Med , vol.351 , pp. 2805-2816
    • Gragoudas, E.S.1    Adamis, A.2    Cunningham, E.T.3
  • 36
    • 0027452475 scopus 로고
    • Age-related macular degeneration histopathologic studies. The 1992 Lorenz E. Zimmerman Lecture
    • Green W.R., and Enger C. Age-related macular degeneration histopathologic studies. The 1992 Lorenz E. Zimmerman Lecture. Ophthalmology 100 (1993) 1519-1535
    • (1993) Ophthalmology , vol.100 , pp. 1519-1535
    • Green, W.R.1    Enger, C.2
  • 37
    • 0028365310 scopus 로고
    • Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells
    • Griendling K.H., Mineri C.A., Ollerenshaw J.D., and Alexander R.W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74 (1994) 1141-1148
    • (1994) Circ Res , vol.74 , pp. 1141-1148
    • Griendling, K.H.1    Mineri, C.A.2    Ollerenshaw, J.D.3    Alexander, R.W.4
  • 38
    • 21144443076 scopus 로고    scopus 로고
    • Rapamycin induces tumor-specific thrombosis via tissue factor in the presence of VEGF
    • Guba M., Yezhelyev M., Eichhorn M.E., et al. Rapamycin induces tumor-specific thrombosis via tissue factor in the presence of VEGF. Blood 105 (2005) 4463-4469
    • (2005) Blood , vol.105 , pp. 4463-4469
    • Guba, M.1    Yezhelyev, M.2    Eichhorn, M.E.3
  • 39
    • 0037453099 scopus 로고    scopus 로고
    • The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis
    • Henry T.D., Annex B.H., McKendall G.R., et al. The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis. Circulation 107 (2003) 1359-1365
    • (2003) Circulation , vol.107 , pp. 1359-1365
    • Henry, T.D.1    Annex, B.H.2    McKendall, G.R.3
  • 40
    • 0030950540 scopus 로고    scopus 로고
    • Angiotensin Converting enzyme inhibition prevents arterial NF-kB activation, MCP-1 expression and macrophage infiltration in a rabbit model of early accelerated atherosclerosis
    • Hernández-Presa M., Bustos C., Ortego M., et al. Angiotensin Converting enzyme inhibition prevents arterial NF-kB activation, MCP-1 expression and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation 95 (1997) 1532-1541
    • (1997) Circulation , vol.95 , pp. 1532-1541
    • Hernández-Presa, M.1    Bustos, C.2    Ortego, M.3
  • 41
    • 0036147982 scopus 로고    scopus 로고
    • Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of atherosclerosis and in cultured vascular smooth muscle cells
    • Hernández-Presa M.A., Martín-Ventura J.L., Ortego M., et al. Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of atherosclerosis and in cultured vascular smooth muscle cells. Atherosclerosis 160 (2002) 49-58
    • (2002) Atherosclerosis , vol.160 , pp. 49-58
    • Hernández-Presa, M.A.1    Martín-Ventura, J.L.2    Ortego, M.3
  • 42
    • 0026395163 scopus 로고
    • The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA
    • Houck K.A., Ferrara N., Winer J., et al. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 5 (1991) 1806-1814
    • (1991) Mol Endocrinol , vol.5 , pp. 1806-1814
    • Houck, K.A.1    Ferrara, N.2    Winer, J.3
  • 43
    • 0027064888 scopus 로고
    • Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms
    • Houck K.A., Leung D.W., Rowland A.M., et al. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 267 (1992) 26031-26037
    • (1992) J Biol Chem , vol.267 , pp. 26031-26037
    • Houck, K.A.1    Leung, D.W.2    Rowland, A.M.3
  • 44
    • 6444220780 scopus 로고    scopus 로고
    • Vascular endothelial growth factor regulates reendothelialization and neointima formation in a mouse model of arterial injury
    • Huttler R., Carrick F.E., Valdiviezo C., et al. Vascular endothelial growth factor regulates reendothelialization and neointima formation in a mouse model of arterial injury. Circulation 110 (2004) 2430-2435
    • (2004) Circulation , vol.110 , pp. 2430-2435
    • Huttler, R.1    Carrick, F.E.2    Valdiviezo, C.3
  • 45
    • 0033594888 scopus 로고    scopus 로고
    • Novel mechanism for endothelial dysfunction. Dysregulation of dimethylarginine dimethylaminohydrolase
    • I to A., Tsao P.S., Adimoolam S., et al. Novel mechanism for endothelial dysfunction. Dysregulation of dimethylarginine dimethylaminohydrolase. Circulation 99 (1999) 3092-3095
    • (1999) Circulation , vol.99 , pp. 3092-3095
    • I to, A.1    Tsao, P.S.2    Adimoolam, S.3
  • 46
    • 0026534274 scopus 로고
    • Platelet-derived growth factor promotes smooth-muscle migration and intimal thickening in a rat model of balloon angioplasty
    • Jawien A., Bowen-Pope D.F., Lindner V., et al. Platelet-derived growth factor promotes smooth-muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest 89 (1992) 507-511
    • (1992) J Clin Invest , vol.89 , pp. 507-511
    • Jawien, A.1    Bowen-Pope, D.F.2    Lindner, V.3
  • 47
    • 0242438697 scopus 로고    scopus 로고
    • Neovascularization in human coronary arteries with lesions of different severity
    • Juan-Babot J.O., Martínez-González J., Berrozpe M., and Badimon L. Neovascularization in human coronary arteries with lesions of different severity. Rev Esp Cardiol 56 (2003) 978-986
    • (2003) Rev Esp Cardiol , vol.56 , pp. 978-986
    • Juan-Babot, J.O.1    Martínez-González, J.2    Berrozpe, M.3    Badimon, L.4
  • 48
    • 0037208589 scopus 로고    scopus 로고
    • Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer
    • Kabbinavar F., Hurwitz H.I., Fehrenbacher L., et al. Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer. J Clin Oncol 21 (2003) 60-65
    • (2003) J Clin Oncol , vol.21 , pp. 60-65
    • Kabbinavar, F.1    Hurwitz, H.I.2    Fehrenbacher, L.3
  • 49
    • 34248639027 scopus 로고    scopus 로고
    • Elimination of neoangiogenesis for plaque stabilization: is there a role for local drug therapy?
    • Kolodgie F.D., Narula J., Yuan C., et al. Elimination of neoangiogenesis for plaque stabilization: is there a role for local drug therapy?. J Am Coll Cardiol 49 (2007) 2093-2101
    • (2007) J Am Coll Cardiol , vol.49 , pp. 2093-2101
    • Kolodgie, F.D.1    Narula, J.2    Yuan, C.3
  • 50
    • 34249695008 scopus 로고    scopus 로고
    • Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neaovascularization due to age-related macular degeneration
    • Lazic R., and Gabric N. Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neaovascularization due to age-related macular degeneration. Ophthalmology 114 (2007) 1179-1185
    • (2007) Ophthalmology , vol.114 , pp. 1179-1185
    • Lazic, R.1    Gabric, N.2
  • 51
    • 0024818355 scopus 로고
    • Vascular endothelial growth factor is a secreted angiogenic mitogen
    • Leung D.W., Cachianes G., Kuang W.J., et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246 (1989) 1306-1309
    • (1989) Science , vol.246 , pp. 1306-1309
    • Leung, D.W.1    Cachianes, G.2    Kuang, W.J.3
  • 52
    • 34548262708 scopus 로고    scopus 로고
    • Pegaptanib 1-year systemic safety results from a safety pharmacokinetic trial in patients with neovascular age-related macular degeneration
    • . Macugen AMD Study Group
    • Apte R.S., Modi M., et al., . Macugen AMD Study Group. Pegaptanib 1-year systemic safety results from a safety pharmacokinetic trial in patients with neovascular age-related macular degeneration. Ophthalmology 114 (2007) 1702-1712
    • (2007) Ophthalmology , vol.114 , pp. 1702-1712
    • Apte, R.S.1    Modi, M.2
  • 53
    • 0032891440 scopus 로고    scopus 로고
    • Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques. A role for apoptosis in plaque thrombogenicity
    • Mallat Z., Bénédicte H., Ohan J., et al. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques. A role for apoptosis in plaque thrombogenicity. Circulation 99 (1999) 348-353
    • (1999) Circulation , vol.99 , pp. 348-353
    • Mallat, Z.1    Bénédicte, H.2    Ohan, J.3
  • 54
    • 23244447710 scopus 로고    scopus 로고
    • Intensive treatment with atorvastatin reduces blood and plaque inflammation in patients with atherosclerotic lesions in one month
    • Martín-Ventura J.L., Blanco-Colio L.M., Gómez-Hernández A., et al. Intensive treatment with atorvastatin reduces blood and plaque inflammation in patients with atherosclerotic lesions in one month. Stroke 36 (2005) 1796-1800
    • (2005) Stroke , vol.36 , pp. 1796-1800
    • Martín-Ventura, J.L.1    Blanco-Colio, L.M.2    Gómez-Hernández, A.3
  • 55
    • 20844438189 scopus 로고    scopus 로고
    • Circulating heat shock protein-27 is decreased in patients with carotid stenosis. A potential novel marker of atherosclerosis
    • Martin-Ventura J.L., Duran M.C., Blanco-Colio L.M., et al. Circulating heat shock protein-27 is decreased in patients with carotid stenosis. A potential novel marker of atherosclerosis. Circulation 110 (2004) 2216-2219
    • (2004) Circulation , vol.110 , pp. 2216-2219
    • Martin-Ventura, J.L.1    Duran, M.C.2    Blanco-Colio, L.M.3
  • 56
    • 0025883342 scopus 로고
    • Nitric oxide: physiology, pathophysiology, and pharmacology
    • Moncada S., Palmer R.M.J., and Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 93 (1991) 109-142
    • (1991) Pharmacol Rev , vol.93 , pp. 109-142
    • Moncada, S.1    Palmer, R.M.J.2    Higgs, E.A.3
  • 57
    • 0028139239 scopus 로고
    • Vascular endothelial growth factor, platelet-derived growth factor, and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro
    • Nicosia R., Nicosia S.V., and Smith M. Vascular endothelial growth factor, platelet-derived growth factor, and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro. Am J Pathol 145 (1994) 1023-1029
    • (1994) Am J Pathol , vol.145 , pp. 1023-1029
    • Nicosia, R.1    Nicosia, S.V.2    Smith, M.3
  • 58
    • 0032580971 scopus 로고    scopus 로고
    • Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis
    • Oemar B.S., Tschudi M.R., Godoy N., et al. Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation 97 (1998) 2494-2498
    • (1998) Circulation , vol.97 , pp. 2494-2498
    • Oemar, B.S.1    Tschudi, M.R.2    Godoy, N.3
  • 59
    • 0029838582 scopus 로고    scopus 로고
    • Reversing endothelial dysfunction with ACE inhibitors. A new trend?
    • Rajagopalan S., and Harrison D.G. Reversing endothelial dysfunction with ACE inhibitors. A new trend?. Circulation 94 (1996) 240-243
    • (1996) Circulation , vol.94 , pp. 240-243
    • Rajagopalan, S.1    Harrison, D.G.2
  • 60
    • 0017662752 scopus 로고
    • Multiple pathways of capillary permeability
    • Renkin E.M. Multiple pathways of capillary permeability. Circ Res 41 (1977) 735-743
    • (1977) Circ Res , vol.41 , pp. 735-743
    • Renkin, E.M.1
  • 61
    • 0034704893 scopus 로고    scopus 로고
    • C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
    • Ridker P.M., Hennekens C.H., Buring J.E., et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342 (2000) 836-843
    • (2000) N Engl J Med , vol.342 , pp. 836-843
    • Ridker, P.M.1    Hennekens, C.H.2    Buring, J.E.3
  • 62
    • 33749445317 scopus 로고    scopus 로고
    • Ranibizumab for neovascular age-related macular degeneration
    • Rosenfeld P.J., Brown D.M., Heier J.S., et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355 (2006) 1419-1431
    • (2006) N Engl J Med , vol.355 , pp. 1419-1431
    • Rosenfeld, P.J.1    Brown, D.M.2    Heier, J.S.3
  • 63
    • 0033520056 scopus 로고    scopus 로고
    • Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease
    • Rosengart T.K., Lee L.Y., Patel S.R., et al. Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation 100 (1999) 468-474
    • (1999) Circulation , vol.100 , pp. 468-474
    • Rosengart, T.K.1    Lee, L.Y.2    Patel, S.R.3
  • 64
    • 0033552883 scopus 로고    scopus 로고
    • Atherosclerosis: an inflammatory disease
    • Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 340 (1999) 115-126
    • (1999) N Engl J Med , vol.340 , pp. 115-126
    • Ross, R.1
  • 65
    • 0342424181 scopus 로고    scopus 로고
    • Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary artery disease
    • Schächinger V., Britten M.B., and Zeiher A.M. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary artery disease. Circulation 101 (2000) 1899-1906
    • (2000) Circulation , vol.101 , pp. 1899-1906
    • Schächinger, V.1    Britten, M.B.2    Zeiher, A.M.3
  • 66
    • 0343797053 scopus 로고    scopus 로고
    • Coronary atherosclerotic disease: pathological background
    • Fuster V. (Ed), Futura Publishing, New York
    • Schwartz C.J., and Chandler A.B. Coronary atherosclerotic disease: pathological background,. In: Fuster V. (Ed). Syndromes of Atherosclerosis (1996), Futura Publishing, New York 17-32
    • (1996) Syndromes of Atherosclerosis , pp. 17-32
    • Schwartz, C.J.1    Chandler, A.B.2
  • 67
    • 0035106148 scopus 로고    scopus 로고
    • Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium
    • Schwesinger C., Yee C., and Rohan R.M. Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium. Am J Pathol 158 (2001) 1161-1172
    • (2001) Am J Pathol , vol.158 , pp. 1161-1172
    • Schwesinger, C.1    Yee, C.2    Rohan, R.M.3
  • 68
    • 0027298232 scopus 로고
    • The endothelium as a regulator of vascular smooth muscle proliferation
    • Scott-Burden T., and Vanhoutte P.M. The endothelium as a regulator of vascular smooth muscle proliferation. Circulation 87 Suppl V (1993) V51-V55
    • (1993) Circulation , vol.87 , Issue.SUPPL. V
    • Scott-Burden, T.1    Vanhoutte, P.M.2
  • 69
    • 0021111648 scopus 로고
    • Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
    • Senger D.R., Galli S.J., Dvorak A.M., et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219 (1983) 983-985
    • (1983) Science , vol.219 , pp. 983-985
    • Senger, D.R.1    Galli, S.J.2    Dvorak, A.M.3
  • 70
    • 0034948743 scopus 로고    scopus 로고
    • Host bone-marrow cells are a source of donor intimal smooth muscle-like cells In murine aortic transplant arteriopathy
    • Shimizu K., Sugiyama S., Aikawa M., et al. Host bone-marrow cells are a source of donor intimal smooth muscle-like cells In murine aortic transplant arteriopathy. Nat Med 7 (2001) 738-741
    • (2001) Nat Med , vol.7 , pp. 738-741
    • Shimizu, K.1    Sugiyama, S.2    Aikawa, M.3
  • 71
    • 6444228734 scopus 로고    scopus 로고
    • The role of vascular endothelial growth factor in restenosis: the controversy continues
    • Shiojima I., and Walsh K. The role of vascular endothelial growth factor in restenosis: the controversy continues. Circulation 110 (2004) 2283-2286
    • (2004) Circulation , vol.110 , pp. 2283-2286
    • Shiojima, I.1    Walsh, K.2
  • 72
    • 16344389190 scopus 로고    scopus 로고
    • Angiogenesis: Where do we stand now?
    • Simons M. Angiogenesis: Where do we stand now?. Circulation 111 (2005) 1556-1566
    • (2005) Circulation , vol.111 , pp. 1556-1566
    • Simons, M.1
  • 73
    • 33745091547 scopus 로고    scopus 로고
    • Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration
    • Spaide R.F., Laud K., Fine H.F., et al. Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina 26 (2006) 383-390
    • (2006) Retina , vol.26 , pp. 383-390
    • Spaide, R.F.1    Laud, K.2    Fine, H.F.3
  • 74
    • 0010596633 scopus 로고
    • Interaction between serum lipoproteins and cellular components of the arterial wall
    • Stein Y., and Stein O. Interaction between serum lipoproteins and cellular components of the arterial wall. Biochem 7 (1977) 313-344
    • (1977) Biochem , vol.7 , pp. 313-344
    • Stein, Y.1    Stein, O.2
  • 75
    • 0034791188 scopus 로고    scopus 로고
    • Vascular endothelial growth factor (VEGF121) protects rats from renal infarction in thrombotic microangiopathy
    • Suga S., Kim Y.G., Joly A., et al. Vascular endothelial growth factor (VEGF121) protects rats from renal infarction in thrombotic microangiopathy. Kidney Int 60 (2001) 1297-1308
    • (2001) Kidney Int , vol.60 , pp. 1297-1308
    • Suga, S.1    Kim, Y.G.2    Joly, A.3
  • 76
    • 0001654669 scopus 로고    scopus 로고
    • Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction
    • Suwaidi J.A., Hamasaki S., Higano S.T., et al. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 101 (2000) 948-954
    • (2000) Circulation , vol.101 , pp. 948-954
    • Suwaidi, J.A.1    Hamasaki, S.2    Higano, S.T.3
  • 77
    • 0025999033 scopus 로고
    • The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing
    • Tischer E., Mitchell R., Hartman T., et al. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266 (1995) 11947-11954
    • (1995) J Biol Chem , vol.266 , pp. 11947-11954
    • Tischer, E.1    Mitchell, R.2    Hartman, T.3
  • 78
    • 0029739620 scopus 로고    scopus 로고
    • Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate
    • Tolentino M.J., Miller J.W., Gragoudas E.S., et al. Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate. Arch Ophthalmol 114 (1996) 964-970
    • (1996) Arch Ophthalmol , vol.114 , pp. 964-970
    • Tolentino, M.J.1    Miller, J.W.2    Gragoudas, E.S.3
  • 79
    • 16944365813 scopus 로고    scopus 로고
    • Tissue factor modulates the thrombogenicity of human atherosclerotic plaques
    • Toschi V., Gallo R., Lettino M., et al. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation 95 (1997) 594-599
    • (1997) Circulation , vol.95 , pp. 594-599
    • Toschi, V.1    Gallo, R.2    Lettino, M.3
  • 80
    • 34248646760 scopus 로고    scopus 로고
    • Total cholesterol content of erythrocyte membranes is increased in patients with acute coronary syndrome: a new marker of clinical instability?
    • Tziakas D.N., Kaski J.C., Chalikias G.K., et al. Total cholesterol content of erythrocyte membranes is increased in patients with acute coronary syndrome: a new marker of clinical instability?. J Am Coll Cardiol 49 (2007) 2081-2089
    • (2007) J Am Coll Cardiol , vol.49 , pp. 2081-2089
    • Tziakas, D.N.1    Kaski, J.C.2    Chalikias, G.K.3
  • 81
    • 0023678963 scopus 로고
    • The endothelium: modulator of vascular smooth-muscle tone
    • Vanhoutte P.M. The endothelium: modulator of vascular smooth-muscle tone. N Engl J Med 319 (1988) 512-513
    • (1988) N Engl J Med , vol.319 , pp. 512-513
    • Vanhoutte, P.M.1
  • 82
    • 33646948521 scopus 로고    scopus 로고
    • Pegaptanib sodium for neovascular age-related macular degeneration. Two-year safety results of the two prospective, multicenter, controlled clinical trials
    • VEGF inhibition study in ocular neovascularisation (VISION) clinical trial group
    • VEGF inhibition study in ocular neovascularisation (VISION) clinical trial group. Pegaptanib sodium for neovascular age-related macular degeneration. Two-year safety results of the two prospective, multicenter, controlled clinical trials. Ophthalmology 113 (1996) 992-1001
    • (1996) Ophthalmology , vol.113 , pp. 992-1001
  • 83
    • 0033506713 scopus 로고    scopus 로고
    • Cellular mechanisms of blood-retinal barrier dysfunction in macular edema
    • Vinores S.A., Derevkanik N.L., Ozaki H., et al. Cellular mechanisms of blood-retinal barrier dysfunction in macular edema. Doc Ophthalmol 97 (1999) 217-228
    • (1999) Doc Ophthalmol , vol.97 , pp. 217-228
    • Vinores, S.A.1    Derevkanik, N.L.2    Ozaki, H.3
  • 84
    • 0033000420 scopus 로고    scopus 로고
    • Large amounts of vascular endothelial growth factor at the site of hemostatic plug formation in vivo
    • Weltermann A., Wolzt M., Petersmann K., et al. Large amounts of vascular endothelial growth factor at the site of hemostatic plug formation in vivo. Arterioscler Thromb Vasc Biol 19 (1999) 1757-1760
    • (1999) Arterioscler Thromb Vasc Biol , vol.19 , pp. 1757-1760
    • Weltermann, A.1    Wolzt, M.2    Petersmann, K.3
  • 85
    • 0033514984 scopus 로고    scopus 로고
    • Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages
    • Xu X.P., Meisel S.R., Ong J.M., et al. Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages. Circulation 99 (1999) 993-998
    • (1999) Circulation , vol.99 , pp. 993-998
    • Xu, X.P.1    Meisel, S.R.2    Ong, J.M.3
  • 86
    • 0042343801 scopus 로고    scopus 로고
    • A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer
    • Yang J.C., Haworth L., Sherry R.M., et al. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. N Engl J Med 349 (2003) 427-434
    • (2003) N Engl J Med , vol.349 , pp. 427-434
    • Yang, J.C.1    Haworth, L.2    Sherry, R.M.3
  • 87
    • 0030022917 scopus 로고    scopus 로고
    • Effects of vascular endothelial growth factor on hemodynamics and cardiac performance
    • Yang R., Thomas G.R., Bunting S., et al. Effects of vascular endothelial growth factor on hemodynamics and cardiac performance. J Cardiovasc Pharmacol 27 (1996) 838-844
    • (1996) J Cardiovasc Pharmacol , vol.27 , pp. 838-844
    • Yang, R.1    Thomas, G.R.2    Bunting, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.